Home
Simcere Pharma

Simcere Pharma Market Share Analysis for May 2026

先声药业官网

Health > Biotechnology and Pharmaceuticals

Domainsimcere.com

Year Founded1995

Employees5001 - 10000

Annual Revenue> $1B

Simcere Pharma

Simcere Pharma (including company regionals)

simcere.com

See more website traffic and engagement information

Simcere Pharma Revenue up to May 2026 is > 1B

revenue generated by Simcere Pharma top domains

Simcere Pharma top domains revenue over 3 years

Revenue for Simcere Pharma top domains

simcere.com> 1B

See more with Sales Intelligence

Total visits to Simcere Pharma's top domains

Understand Simcere Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

simcere.com9.9K

See more with Sales Intelligence

Avg. visit duration in Simcere Pharma's top domains

Analyze Simcere Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

simcere.com00:00:18

See more with Sales Intelligence

Avg. pageviews on Simcere Pharma's top domains

See how Simcere Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

simcere.com1.87

See more with Sales Intelligence

Simcere Pharma top competitors by domain

Top similar sites in May 2026, ranked by their affinity

alphamabonc.comCompany NameAlphamab OncologyEmployees201 - 500HQChina, SuzhouAnnual revenue$50M - $75MTotal visits4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Simcere Pharma

These are the website technologies, by industry, used by Simcere Pharma top domains

Conversion & Analytics (3)

SirData

Mobile (3)

Meta Viewport

Audio Video Media (2)

VideoJS

Advertising (1)

PubMatic

More Technologies

1

See all

News & Signals from Simcere Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSimcere Pharmaceutical Group partnered with Stanford Health Care on Jun 12th '26.Simcere and Stanford launch IPF research collaboration [1] [US - 12 jun 2026].

NewsSimcere Pharmaceutical Group is developing IPF therapies.Simcere and Stanford partner to develop IPF therapies.

NewsSimcere Pharmaceutical Group partnered with Stanford Medicine on Jun 12th '26.China-based Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to advance a first-in-class novel molecule for idiopathic pulmonary fibrosis.